Healthcare & Life Sciences
GlySens
United Statesglysens.com
GlySens is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
series-c-plus
series-c-plus
Stage
3
Investors
About GlySens
GlySens is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
GlySens develops a long-term implantable device that continuously monitors blood glucose levels and transmits the data to smartphones and other devices to aid diabetes management.
Explore GlySens's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.